Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant NOTCH3 (Tarextumab Biosimilar) antibody

The Human Monoclonal anti-NOTCH3 (Tarextumab Biosimilar) antibody (ABIN7598024) specifically detects NOTCH3 (Tarextumab Biosimilar). The antibody is reactive with Human samples.
Catalog No. ABIN7598024
-15% Promotion 2026
$465.82
$548.02
save $82.20 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to: United States
Delivery in 12 to 14 Business Days

Quick Overview for Recombinant NOTCH3 (Tarextumab Biosimilar) antibody (ABIN7598024)

Target

NOTCH3 (Tarextumab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 3
Human

Clonality

  • 3
Monoclonal

Conjugate

  • 2
  • 1
This NOTCH3 (Tarextumab Biosimilar) antibody is un-conjugated

Application

Please inquire

Grade

Research Grade
  • Expression System

    Mammalian cells

    Purpose

    Research Grade Tarextumab Biosimilar Antibody

    Specificity

    N2ICD, N2ECD, NOTCH2, hN2, Neurogenic locus notch homolog protein 2, Notch 2, Neurogenic locus notch homolog protein 3, NOTCH3, Notch 3

    Purification

    Protein A or G purified from cell culture supernatant.

    Purity

    >95 % by SDS-PAGE.

    Isotype

    IgG2 kappa
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.68 mg/mL

    Buffer

    0.01M PBS, pH 7.4.

    Storage

    4 °C,-20 °C,-80 °C

    Storage Comment

    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

    Expiry Date

    12 months
  • Target

    NOTCH3 (Tarextumab Biosimilar)

    Alternative Name

    Tarextumab Biosimilar

    Target Type

    Biosimilar

    Background

    N2ICD, N2ECD, NOTCH2, hN2, Neurogenic locus notch homolog protein 2, Notch 2, Neurogenic locus notch homolog protein 3, NOTCH3, Notch 3

    UniProt

    Q04721, Q9UM47

    CAS-No

    1359940-55-8
You are here:
Chat with us!